Chitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cells

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Wang, I Jong ^a   Jhuang, Min Chao ^b   Chen, Yu Hsin ^b   Yeh, Lung Kun ^c   Liu, Chia Yang ^d   Young, Tai Horng ^b,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 IMINOTHIOLANE; ADENOVIRUS VECTOR; CHITOSAN; MALEIMIDE DERIVATIVE; N[GAMMA MALEIMIDOBUTYRYLOXY]SUCCINIMIDE ESTER; SULFIDE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT DNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CORNEA EPITHELIUM; COW; CROSS LINKING; EMBRYO; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PARTICLE SIZE; SURFACE CHARGE; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CAPSID; VIRUS PARTICLE; ZETA POTENTIAL; ADENOVIRUS; ANIMAL; CATTLE; CELL MEMBRANE; CYTOLOGY; GENE VECTOR; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY; TRANSGENE; VIROLOGY; VIRUS ATTACHMENT;

ADENOVIRIDAE; BOVINAE; MIRIDAE;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, NEUTRALIZING; CAPSID; CATTLE; CELL MEMBRANE; CHITOSAN; DNA, RECOMBINANT; EPITHELIUM, CORNEAL; GENETIC VECTORS; TRANSFECTION; TRANSGENES; VIRUS ATTACHMENT;

EID: 77957760034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012085     Document Type: Article

References (45)

1. Mohan RR, Sharma A, Netto MV, Sinha S, Wilson SE (2005) Gene therapy in the cornea. Prog Retin Eye Res 24: 537-559.
2. Arakisasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, et al. (1995) An Sv40-Immortalized Human Corneal Epithelial-Cell Line and Its Characterization. Investigative Ophthalmology & Visual Science 36: 614-621.
3. Borras T, Gabelt BT, Klintworth GK, Peterson JC, Kaufman PL (2001) Noninvasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. Journal of Gene Medicine 3: 437-449.
4. Borras T, Tamm ER, Zigler JS (1996) Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Investigative Ophthalmology & Visual Science 37: 1282-1293.
5. Budenz DL, Bennett J, Alonso L, Maguire A (1995) In-Vivo Gene-Transfer into Murine Corneal Endothelial and Trabecular Meshwork Cells. Investigative Ophthalmology & Visual Science 36: 2211-2215.
6. Carlson EC, Liu CY, Yang XP, Gregory M, Ksander B, et al. (2004) In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter. Investigative Ophthalmology & Visual Science 45: 2194-2200.
7. Mashhour B, Couton D, Perricaudet M, Briand P (1994) In-Vivo Adenovirus-Mediated Gene-Transfer into Ocular-Tissues. Gene Therapy 1: 122-126.
8. Tsubota K, Inoue H, Ando K, Ono M, Yoshino K, et al. (1998) Adenovirusmediated gene transfer to the ocular surface epithelium. Experimental Eye Research 67: 531-538.
9. Alemany R, Suzuki K, Curiel DT (2000) Blood clearance rates of adenovirus type 5 in mice. Journal of General Virology 81: 2605-2609.
10. Croyle MA, Chirmule N, Zhang Y, Wilson JM (2002) PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Human Gene Therapy 13: 1887-1900.
11. Croyle MA, Yu QC, Wilson JM (2000) Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Human Gene Therapy 11: 1713-1722.
12. Mok H, Palmer DJ, Ng P, Barry MA (2005) Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther 11: 66-79.
13. Chillon M, Lee JH, Fasbender A, Welsh MJ (1998) Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Therapy 5: 995-1002.
14. Eto Y, Gao JQ, Sekiguchi F, Kurachi S, Katayama K, et al. (2005) PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J Gene Med 7: 604-612.
15. O'Riordan CR, Lachapelle A, Delgado C, Parkes V, Wadsworth SC, et al. (1999) PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Human Gene Therapy 10: 1349-1358.
16. Croyle MA, Chirmule N, Zhang Y, Wilson JM (2001) ''Stealth'' adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 75: 4792-4801.
17. Lanciotti J, Song A, Doukas J, Sosnowski B, Pierce G, et al. (2003) Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Molecular Therapy 8: 99-107.
18. Ogawara KI, Rots MG, Kok RJ, Moorlag HE, van Loenen AM, et al. (2004) A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Human Gene Therapy 15: 433-443.
19. Stevenson M, Boos E, Herbert C, Hale A, Green N, et al. (2006) Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells. Gene Therapy 13: 356-368.
20. Green NK, Herbert CW, Hale SJ, Hale AB, Mautner V, et al. (2004) Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther 11: 1256-1263.
21. Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, et al. (2001) Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther 8: 341-348.
22. Stevenson M, Hale AB, Hale SJ, Green NK, Black G, et al. (2007) Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins. Cancer Gene Ther 14: 335-345.
23. Harding SE (2003) Mucoadhesive interactions. Biochem Soc Trans 31: 1036-1041.
24. Borchard G, Luessen HL, deBoer AG, Verhoef JC, Lehr CM, et al. (1996) The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption.3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. Journal of Controlled Release 39: 131-138.
25. Croyle MA, Cheng X, Sandhu A, Wilson JM (2001) Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo. Mol Ther 4: 22-28.
26. Kawamata Y, Nagayama Y, Nakao K, Mizuguchi H, Hayakawa T, et al. (2002) Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro. Biomaterials 23: 4573-4579.
27. Tao W, Liou GI, Wu X, Abney TO, Reinach PS (1995) ETB and epidermal growth factor receptor stimulation of wound closure in bovine corneal epithelial cells. Invest Ophthalmol Vis Sci 36: 2614-2622.
28. Wilcox GE (1969) Preparation of primary bovine corneal epithelial cell cultures for use in virological investigations. Appl Microbiol 18: 268-269.
29. Bernkop-Schnurch A, Hornof M, Zoidl T (2003) Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 260: 229-237.
30. Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S, et al. (2005) Thiolation of chitosan. Attachment of proteins via thioether formation. Biomacromolecules 6: 880-884.
31. Stewart PL, Fuller SD, Burnett RM (1993) Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. Embo J 12: 2589-2599.
32. O'Neal D, Harrip P, Dragicevic G, Rae D, Best JD (1998) A comparison of LDL size determination using gradient gel electrophoresis and light-scattering methods. Journal of Lipid Research 39: 2086-2090.
33. Helmke RJ, Heberling RL, Kalter SS (1970) Technique for viral neutralization antibody surveys in primary microcultures. Applied Microbiology 20: 986-988.
34. De Campos AM, Sanchez A, Gref R, Calvo P, Alonso MJ (2003) The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. European Journal of Pharmaceutical Sciences 20: 73-81.
35. Alonso MJ, Sanchez A (2003) The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 55: 1451-1463.
36. Enriquez de Salamanca A, Diebold Y, Calonge M, Garcia-Vazquez C, Callejo S, et al. (2006) Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci 47: 1416-1425.
37. Diebold Y, Jarrin M, Saez V, Carvalho EL, Orea M, et al. (2007) Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28: 1553-1564.
38. De Campos AM, Diebold Y, Carvalho EL, Sanchez A, Alonso MJ (2004) Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 21: 803-810.
39. Croyle MA, Le HT, Linse KD, Cerullo V, Toietta G, et al. (2005) PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. Gene Ther 12: 579-587.
40. Kreppel F, Gackowski J, Schmidt E, Kochanek S (2005) Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors. Mol Ther 12: 107-117.
41. Bonsted A, Engesaeter BO, Hogset A, Maelandsmo GM, Prasmickaite L, et al. (2006) Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor. J Gene Med 8: 286-297.
42. Arcasoy SM, Latoche JD, Gondor M, Pitt BR, Pilewski JM (1997) Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther 4: 32-38.
43. Fasbender A, Zabner J, Chillon M, Moninger TO, Puga AP, et al. (1997) Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 272: 6479-6489.
44. Arcasoy SM, Latoche J, Gondor M, Watkins SC, Henderson RA, et al. (1997) MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells. Am J Respir Cell Mol Biol 17: 422-435.
45. Rosenblatt MI, Azar DT (2004) Gene therapy of the corneal epithelium. International Ophthalmology Clinics 44: 81-90.